Remicade 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FA0TZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,564
Award facts
- Contract value 100% obligated
- $10,564.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,564.00 delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of December 23, 2025. This is a firm fixed price, non-set-aside contract awarded competitively on December 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
Remicade (infliximab) is a TNF inhibitor biologic used to treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, and other autoimmune conditions, making it a critical pharmaceutical in military and federal healthcare systems' formularies. AmerisourceBergen's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract vehicle facilitates pharmaceutical procurement for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen's demonstrated capability to manage both high-volume and specialized pharmaceutical deliveries through competitive federal procurement.
Quick answers
Who was awarded contract SPE2DR26FA0TZ?
SPE2DR26FA0TZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FA0TZ worth?
The government has obligated $10,564 on SPE2DR26FA0TZ.
Is contract SPE2DR26FA0TZ an order under another contract?
Yes. SPE2DR26FA0TZ is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0TZ competed?
The extent of competition for SPE2DR26FA0TZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award